Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of MW032 and Xgeva® in Healthy Adults
Clinical trial NCT04798326 · COMPLETED
Trial details
- NCT number
- NCT04798326
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-25
- Primary completion
- 2020-01-10
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.